Login / Signup

HIV-1 Group M Capsid Amino Acid Variability: Implications for Sequence Quality Control of Genotypic Resistance Testing.

Kaiming TaoSoo-Yon RheePhilip L TzouZachary A OsmanSergei L Kosakovsky PondSusan P HolmesRobert W Shafer
Published in: Viruses (2023)
Knowing the distribution of usual capsid mutations is essential for sequence quality control. Comparing capsid sequences from lenacapavir-treated and lenacapavir-naïve individuals will enable the identification of additional mutations potentially associated with lenacapavir therapy.
Keyphrases
  • quality control
  • amino acid
  • antiretroviral therapy
  • hiv infected
  • hiv positive
  • hepatitis c virus
  • human immunodeficiency virus
  • hiv testing
  • hiv aids
  • stem cells
  • cell therapy
  • bioinformatics analysis
  • smoking cessation